CORCEPT THERAPEUTICS INC Accrued Income Taxes, Current
CORCEPT THERAPEUTICS INC (CORT) had Accrued Income Taxes, Current of $191.00 thousand as of 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current › Taxes Payable, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2025-02-26
- 2024-12-31: Accrued Income Taxes, Current $191.00K.
- 2024-03-31: Accrued Income Taxes, Current $13.46M.
- 2023-12-31: Accrued Income Taxes, Current $1.81M.
- 2023-09-30: Accrued Income Taxes, Current $30.04M.
| Period end | Accrued Income Taxes, Current | Accrued Income Taxes, Current as first filed |
|---|---|---|
| 2024-12-31 | $191.00K 10-K · filed 2025-02-26 | |
| 2024-03-31 | $13.46M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $1.81M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $30.04M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $19.49M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $8.59M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $89.00K 10-K · filed 2024-02-15 | $15.51M 10-K · filed 2023-02-28 |
| 2022-03-31 | $11.52M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $13.34M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $10.14M 10-K · filed 2022-02-15 | |
| 2020-09-30 | $7.67M 10-Q · filed 2020-11-03 | |
| 2020-06-30 | $5.62M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $4.21M 10-Q · filed 2020-05-04 | |
| 2019-12-31 | $12.33M 10-K · filed 2021-02-23 | $472.00K 10-K · filed 2020-02-24 |
| 2019-09-30 | $974.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $2.46M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.54M 10-K · filed 2020-02-24 | |
| 2018-09-30 | $1.58M 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $687.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $728.00K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $66.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |